论文部分内容阅读
目的观察天佛参口服液联合化疗治疗原发性非小细胞肺癌属气阴两虚证的安全性和有效性.并总结试验过程中的护理经验。方法对20例受试者选择采用含铂两药联合化疗方案,并连续服用天佛参口服液.观察受试者服用2-3个周期的各种情况。结果 20例患者中.脱落4例。共16例完成试验。16例经治疗后.完全缓解0例.部分缓解9例,稳定5例,进展2例。采用中医症候评价为:临床痊愈0例.显效10例.有效4例.无效2例.结论天佛参口服液能明显改善化疗后气阴两虚证.提高受试者生活质量.同时减轻化疗引起的毒副反应;同时.及时有效的护理工作对试验的顺利完成十分重要。
Objective To observe the safety and effectiveness of Tianfo Shen oral liquid combined with chemotherapy in the treatment of primary non-small cell lung cancer (NSCLC), and to sum up the experience of nursing during the trial. Methods Twenty subjects were enrolled in the study, and were treated with platinum-containing combination chemotherapy and continuous oral administration of Tianfushen oral liquid. All subjects were treated with 2-3 cycles. Results 20 patients in 4 cases. A total of 16 cases completed the test. Of the 16 cases, 0 were completely relieved after treatment, 9 were partially relieved, 5 were stable, and 2 were progressive. TCM syndromes were evaluated as: clinical recovery in 0 cases, markedly effective in 10 cases, effective in 4 cases and ineffective in 2 cases.Conclusion Tianfushen oral liquid can obviously improve the Qi-Yin Deficiency Syndrome after chemotherapy, improve the quality of life of the subjects, relieve chemotherapy Caused by the side effects; the same time, timely and effective care work on the successful completion of the trial is very important.